These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27023275)

  • 1. An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions.
    Syedbasha M; Linnik J; Santer D; O'Shea D; Barakat K; Joyce M; Khanna N; Tyrrell DL; Houghton M; Egli A
    J Vis Exp; 2016 Mar; (109):. PubMed ID: 27023275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach.
    Packeu A; Wennerberg M; Balendran A; Vauquelin G
    Br J Pharmacol; 2010 Nov; 161(6):1311-28. PubMed ID: 20946109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titration ELISA as a Method to Determine the Dissociation Constant of Receptor Ligand Interaction.
    Eble JA
    J Vis Exp; 2018 Feb; (132):. PubMed ID: 29553569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding assays at equilibrium: validation and interpretation.
    Hulme EC; Trevethick MA
    Br J Pharmacol; 2010 Nov; 161(6):1219-37. PubMed ID: 20132208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
    Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
    J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ran binding protein 9 (RanBPM) binds IFN-λR1 in the IFN-λ signaling pathway.
    Zhang J; Cong X; Zhaoqiao J; Yang X; Li M; Chen H; Mi R; Jin G; Liu F; Huang BR
    Sci China Life Sci; 2017 Sep; 60(9):1030-1039. PubMed ID: 28547582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA-based assay for scatchard analysis of ligand-receptor interactions.
    Vieira A
    Mol Biotechnol; 1998 Dec; 10(3):247-50. PubMed ID: 9951704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating binding affinities of the nicotinic receptor for low-efficacy ligands using mixtures of agonists and two-dimensional concentration-response relationships.
    Purohit Y; Grosman C
    J Gen Physiol; 2006 Jun; 127(6):719-35. PubMed ID: 16735756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the two-dimensional interaction rate constants of a cytokine receptor complex.
    Gavutis M; Jaks E; Lamken P; Piehler J
    Biophys J; 2006 May; 90(9):3345-55. PubMed ID: 16473899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.
    Barta P; Volkova M; Dascalu A; Spiegelberg D; Trejtnar F; Andersson K
    J Pharmacol Toxicol Methods; 2014; 70(2):145-51. PubMed ID: 25084055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds.
    Sykes DA; Dowling MR; Charlton SJ
    Curr Protoc Pharmacol; 2010 Sep; Chapter 9():Unit 9.14. PubMed ID: 22294377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of solid-phase antigen in competition enzyme-linked immunosorbent assays (ELISAs) on calculated antigen-antibody dissociation constants.
    Seligman SJ
    J Immunol Methods; 1994 Jan; 168(1):101-10. PubMed ID: 8288886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New capabilities in determining the binding parameters for ligand-receptor interaction.
    Bobrovnik S
    J Biochem Biophys Methods; 2005 Oct; 65(1):30-44. PubMed ID: 16188321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ELISA-Based Screening Platform for Ligand-Receptor Discovery.
    Ozgul S; von Daake S; Kakehi S; Sereni D; Denissova N; Hanlon C; Huang YJ; Everett JK; Yin C; Montelione GT; Comoletti D
    Methods Enzymol; 2019; 615():453-475. PubMed ID: 30638538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression, purification, and use of a soluble human interleukin-4 receptor alpha-chain/Ig gamma 1 fusion protein for ligand binding studies. Characterization of ligand binding to soluble IL-4 receptor alpha-chain by surface plasmon resonance measurements and by microtiter-plate-based ELISA with biotinylated IL-4.
    Seipelt I; Hoffmann SH; Schmidt J; Engels JW; Beckers T
    Biochem Biophys Res Commun; 1997 Oct; 239(2):534-42. PubMed ID: 9344865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of radioligand specific activity using competition binding assays.
    Wiener HL; Reith ME
    Anal Biochem; 1992 Nov; 207(1):58-62. PubMed ID: 1489100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium, affinity, dissociation constants, IC5O: Facts and fantasies.
    Barbet J; Huclier-Markai S
    Pharm Stat; 2019 Oct; 18(5):513-525. PubMed ID: 30977282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations.
    Corti A; Poiesi C; Merli S; Cassani G
    J Immunol Methods; 1994 Dec; 177(1-2):191-8. PubMed ID: 7822826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.